These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 31748440)
1. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy. Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440 [TBL] [Abstract][Full Text] [Related]
2. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid. Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study. Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548 [TBL] [Abstract][Full Text] [Related]
4. Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel. Izumoto S; Miyauchi M; Tasaki T; Okuda T; Nakagawa N; Nakano N; Kato A; Fujita M Anticancer Res; 2018 Jul; 38(7):4361-4366. PubMed ID: 29970574 [TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study. Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275 [TBL] [Abstract][Full Text] [Related]
6. Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy. Kim JS; Kim WS; Sung WY; Woo H Epilepsy Behav; 2024 May; 154():109740. PubMed ID: 38547767 [TBL] [Abstract][Full Text] [Related]
7. Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. Vecht C; Duran-Peña A; Houillier C; Durand T; Capelle L; Huberfeld G J Neurooncol; 2017 Jul; 133(3):603-607. PubMed ID: 28492978 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy. Kanemura H; Sano F; Aihara M Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990 [TBL] [Abstract][Full Text] [Related]
9. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440 [TBL] [Abstract][Full Text] [Related]
11. Levetiracetam monotherapy--outcomes from an epilepsy clinic. Stephen LJ; Kelly K; Parker P; Brodie MJ Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583 [TBL] [Abstract][Full Text] [Related]
12. Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy. Hasegawa N; Tohyama J Epilepsy Behav; 2021 Mar; 116():107644. PubMed ID: 33549477 [TBL] [Abstract][Full Text] [Related]
13. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657 [TBL] [Abstract][Full Text] [Related]
14. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy. Hattori EY; Arakawa Y; Mineharu Y; Furukawa K; Terada Y; Yamao Y; Tanji M; Kikuchi T; Miyamoto S BMC Cancer; 2023 Sep; 23(1):849. PubMed ID: 37697277 [TBL] [Abstract][Full Text] [Related]
15. Is the anticonvulsant activity of levetiracetam dose-dependent? Lamouret V; Kurth C; Intravooth T; Steinhoff BJ Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757 [TBL] [Abstract][Full Text] [Related]
16. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis. Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318 [TBL] [Abstract][Full Text] [Related]
17. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model. Wu T; Ido K; Ohgoh M; Hanada T Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244 [TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651 [TBL] [Abstract][Full Text] [Related]
19. Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre. Morano A; Fattouch J; Albini M; Casciato S; Fanella M; Basili LM; Viganò A; Manfredi M; Giallonardo AT; Di Bonaventura C J Neurol Sci; 2018 Jul; 390():67-74. PubMed ID: 29801910 [TBL] [Abstract][Full Text] [Related]
20. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]